Vera Therapeutics CEO Marshall Fordyce's 2023 pay slips 16% to $3.4M
Vera Therapeutics reports 2023 executive compensation
By ExecPay News
Published: April 3, 2024
Vera Therapeutics reported fiscal year 2023 executive compensation information on April 3, 2024.
In 2023, three executives at Vera Therapeutics received on average a compensation package of $2.1M, a 24% decrease compared to previous year.
Average pay of disclosed executives at Vera Therapeutics
Marshall Fordyce, Chief Executive Officer, received $3.4M in total, which decreased by 16% compared to 2022. 73% of Fordyce's compensation, or $2.5M, was in option awards. Fordyce also received $32K in bonus, $292K in non-equity incentive plan, as well as $586K in salary.
Sean Grant, Chief Financial Officer, received a compensation package of $1.8M, which decreased by 29% compared to previous year. 64% of the compensation package, or $1.1M, was in option awards.
Celia Lin, Chief Medical Officer, earned $1M in 2023, a 36% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 3, 2024.